These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 31547912

  • 1. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
    Dutra E, Lee J, Torbati T, Garcia M, Merz CNB, Shufelt C.
    Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
    [Abstract] [Full Text] [Related]

  • 2. Hormone Therapy for Transgender Adults.
    Radix A.
    Urol Clin North Am; 2019 Nov; 46(4):467-473. PubMed ID: 31582021
    [Abstract] [Full Text] [Related]

  • 3. Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk.
    Martinez C, Rikhi R, Haque T, Fazal A, Kolber M, Hurwitz BE, Schneiderman N, Brown TT.
    Curr Probl Cardiol; 2020 May; 45(5):100396. PubMed ID: 30340769
    [Abstract] [Full Text] [Related]

  • 4. Endocrinology of Transgender Medicine.
    T'Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V.
    Endocr Rev; 2019 Feb 01; 40(1):97-117. PubMed ID: 30307546
    [Abstract] [Full Text] [Related]

  • 5. Transgender patients and the role of the coagulation clinician.
    Connors JM, Middeldorp S.
    J Thromb Haemost; 2019 Nov 01; 17(11):1790-1797. PubMed ID: 31465627
    [Abstract] [Full Text] [Related]

  • 6. Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.
    Rytz CL, Pattar BSB, Mizen SJ, Lieb P, Parsons Leigh J, Saad N, Dumanski SM, Beach LB, Marshall Z, Newbert AM, Peace L, Ahmed SB.
    Circ Cardiovasc Qual Outcomes; 2024 Sep 01; 17(9):e011024. PubMed ID: 39022828
    [Abstract] [Full Text] [Related]

  • 7. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C, Monita M, Liu M.
    Climacteric; 2024 Jun 01; 27(3):227-235. PubMed ID: 38597210
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular disease in transgender people: recent research and emerging evidence.
    Connelly PJ, Delles C.
    Cardiovasc Res; 2021 Dec 17; 117(14):e174-e176. PubMed ID: 34568899
    [No Abstract] [Full Text] [Related]

  • 9. Insights Into the Cardiomodulatory Effects of Sex Hormones: Implications in Transgender Care.
    Shawky NM, Reckelhoff JF, Alexander BT, Yanes Cardozo LL.
    Hypertension; 2023 Sep 17; 80(9):1810-1820. PubMed ID: 37462057
    [Abstract] [Full Text] [Related]

  • 10. [Hormone treatment of transgender people: Long-term health effects and safety].
    de Blok CJM, Wiepjes CM, Nota NM, den Heijer M.
    Ned Tijdschr Geneeskd; 2020 Jul 23; 164():. PubMed ID: 32757514
    [Abstract] [Full Text] [Related]

  • 11. Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy.
    Aranda G, Mora M, Hanzu FA, Vera J, Ortega E, Halperin I.
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Jul 23; 66(6):385-392. PubMed ID: 30704917
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO, Dreijerink KMA, Wiepjes CM, Kok AAL, van Schoor NM, Huisman M, den Heijer M, Kreukels BPC.
    J Sex Med; 2021 Aug 23; 18(8):1434-1443. PubMed ID: 34247950
    [Abstract] [Full Text] [Related]

  • 13. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D, Spaggiari G, Marinelli L, Cacciani M, Scipio S, Bichiri A, Profeta A, Granata ARM, Simoni M, Lanfranco F, Manieri C, Ghigo E, Motta G.
    J Endocrinol Invest; 2024 May 23; 47(5):1091-1100. PubMed ID: 37889433
    [Abstract] [Full Text] [Related]

  • 14. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA, Georgakis MK, Dimitriou NG, Vichos T, Katsimpris A, Petridou ET, Papadopoulos FC.
    Psychoneuroendocrinology; 2020 Sep 23; 119():104721. PubMed ID: 32512250
    [Abstract] [Full Text] [Related]

  • 15. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
    Rowniak S, Bolt L, Sharifi C.
    JBI Database System Rev Implement Rep; 2019 Sep 23; 17(9):1826-1854. PubMed ID: 31021971
    [Abstract] [Full Text] [Related]

  • 16. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D, T'Sjoen G, Ravn P, Andersen MS.
    Eur J Endocrinol; 2021 Jun 28; 185(2):R49-R63. PubMed ID: 34081614
    [Abstract] [Full Text] [Related]

  • 17. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM, Nota NM, de Blok CJM, Klaver M, de Vries ALC, Wensing-Kruger SA, de Jongh RT, Bouman MB, Steensma TD, Cohen-Kettenis P, Gooren LJG, Kreukels BPC, den Heijer M.
    J Sex Med; 2018 Apr 28; 15(4):582-590. PubMed ID: 29463477
    [Abstract] [Full Text] [Related]

  • 18. Metabolic and cardiovascular risks of hormone treatment for transgender individuals.
    de Silva NL, Dimakopoulou A, Quinton O, Jayasena CN.
    Best Pract Res Clin Endocrinol Metab; 2024 Sep 28; 38(5):101907. PubMed ID: 38942618
    [Abstract] [Full Text] [Related]

  • 19. Transgender men: clinical care and implications in reproductive medicine: introduction.
    de Ziegler D, de Sutter P.
    Fertil Steril; 2021 Oct 28; 116(4):919-921. PubMed ID: 34399947
    [Abstract] [Full Text] [Related]

  • 20. Exploring Health and Transition-Related Needs in Polish Transgender and Non-Binary Individuals.
    Koziara K, Mijas ME, Wycisk J, Pliczko MP, Grabski B.
    J Sex Med; 2021 Jun 28; 18(6):1110-1121. PubMed ID: 34108108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.